https://www.vysnova.com/wp-content/uploads/2021/10/covid-study.jpg 1067 1600 Julixa Newman https://www.vysnova.com/wp-content/uploads/2023/05/Untitled-340-×-156-px.png Julixa Newman2021-10-26 10:30:062021-10-26 10:30:06Project Spotlight and Update: Applied Research to Address the Coronavirus (COVID-19) Emerging Public Health Emergency
The study aims, among participants reporting COVID-like illnesses, to calculate the incidence of SARS-CoV-2 infections and report the incidence among the general population, health care workers, minorities, and other specific groups.
https://www.vysnova.com/wp-content/uploads/2021/10/Screen-Shot-2021-10-26-at-10.13.58-AM.jpg 510 687 Julixa Newman https://www.vysnova.com/wp-content/uploads/2023/05/Untitled-340-×-156-px.png Julixa Newman2021-10-26 10:21:262021-10-26 10:21:49Project Update and Spotlight: NAMRU 6-RASS
NAMRU-6 provides sustainable infectious diseases research support to the host nation Ministry of Health, other government agencies, universities and military through field studies, infectious diseases surveillance and epidemiologic studies, vaccine and drug clinical trials, test/evaluation of technologies and training...
https://www.vysnova.com/wp-content/uploads/2021/10/Epidemiology-Research.jpg 1067 1600 Julixa Newman https://www.vysnova.com/wp-content/uploads/2023/05/Untitled-340-×-156-px.png Julixa Newman2021-10-26 10:05:382021-10-26 10:05:38Project Spotlight and Update: Southeast Asia Bio-Surveillance and Epidemiology Research II (SABER II)
SABER II team continues providing support to NAMRU-2 in the conduct of biomedical, epidemiological, and clinical research efforts including rolling out research projects, onboarding new staff, and partners, negotiating new subcontracts, modifying the existing subcontracts, setting up and managing project activities.
https://www.vysnova.com/wp-content/uploads/2021/10/Screen-Shot-2021-10-26-at-9.34.12-AM.jpg 426 576 Julixa Newman https://www.vysnova.com/wp-content/uploads/2023/05/Untitled-340-×-156-px.png Julixa Newman2021-10-26 09:41:232021-10-26 09:56:02Capacity Building for Ebola Response in DRC (Cooperative Agreement)
Vysnova is a Prime awardee for the Cooperative Agreement funded by CDC. Under this Cooperative Agreement, Vysnova works with CDC’s Viral Special Pathogens Branch (VSPB), which is responsible for the research, prevention, control, and management of a wide range of infectious diseases caused by deadly viruses such as Ebola, Lassa, Nipah, Crimean-Congo hemorrhagic fever, Rift Valley fever, and hantaviruses.
https://www.vysnova.com/wp-content/uploads/2021/10/Screen-Shot-2021-10-13-at-9.25.59-PM.jpg 558 578 Julixa Newman https://www.vysnova.com/wp-content/uploads/2023/05/Untitled-340-×-156-px.png Julixa Newman2021-10-13 21:45:112021-10-15 12:13:24Vysnova Attends US-Kenya SME Trade Initiative
Vysnova Partners, Inc. (Vysnova) was delighted to join the President of Kenya, Mr. Uhuru Kenyatta, and several members of his cabinet, at the official signing of a private sector agreement that seeks to expand trade and investments between Kenya and the United States of America.
https://www.vysnova.com/wp-content/uploads/2021/09/covid-vaccine.jpg 1000 1500 Julixa Newman https://www.vysnova.com/wp-content/uploads/2023/05/Untitled-340-×-156-px.png Julixa Newman2021-09-16 10:53:512021-09-20 10:30:10Success Story: Survey of Immune Response to Coronavirus Disease 2019 Infections (SIM-COVID)
Vysnova Partners provides program management support for activities to develop and perform a cross-sectional serology protocol designed to assess the burden and distribution of SARS-CoV-2 infections among US Department of Defense (DoD) forces by measuring antibodies against the SARS-CoV-2 virus...
https://www.vysnova.com/wp-content/uploads/2018/11/vysnova-globe-white-background.jpg 358 318 Julixa Newman https://www.vysnova.com/wp-content/uploads/2023/05/Untitled-340-×-156-px.png Julixa Newman2021-08-23 09:57:592021-08-27 16:44:43Survey of Adherence with COVID-19 Prevention Behaviors During the 2020 Thanksgiving and Winter Holidays Among Members of the COVID-19 Community Research Partnership
Vysnova is proud to be a co-collaborator of a publication in the Journal of Community Health, a peer-reviewed publication that offers original articles on the practice, teaching, and research of community health. Survey of Adherence with COVID‐19 Prevention Behaviors During the 2020 Thanksgiving and Winter Holidays Among Members of the COVID‐19 Community Research Partnership
https://www.vysnova.com/wp-content/uploads/2021/07/Vysnova-Ectoparasite-Lab-1.jpg 1066 1600 Julixa Newman https://www.vysnova.com/wp-content/uploads/2023/05/Untitled-340-×-156-px.png Julixa Newman2021-07-29 11:32:342021-07-29 11:32:34Project Spotlight: Ectoparasite Surveillance in Mongolia
NAMRU-2’s mission is to monitor and characterize emerging and re-emerging infectious diseases of military and public health importance and to develop mitigation strategies against these threats in partnership with host nation, international and U.S. agencies in Southeast Asia.
https://www.vysnova.com/wp-content/uploads/2021/06/Screen-Shot-2021-06-28-at-10.31.27-AM.png 252 332 Julixa Newman https://www.vysnova.com/wp-content/uploads/2023/05/Untitled-340-×-156-px.png Julixa Newman2021-06-28 10:43:552021-06-28 11:08:56Success Story: Strengthening Laboratory Capacity in DRC
Between March 15 and April 3, 2021, Dr. Christopher Mores, Sarah Tritsch, and Abbey Porzucek of George Washington University (GWU), Vysnova’s sub awardee, traveled to the Democratic Republic of Congo (DRC) to build relationships with then the Institut National pour la Recherche Biomedicale (INRB), DRC Ministry of Health (MoH), Provincial Division of Health (DPS), and the laboratory team in Ingende.
https://www.vysnova.com/wp-content/uploads/2021/06/WOUND-INFECTIONS-DEPARTMENT-STUDY.jpg 1421 2048 Julixa Newman https://www.vysnova.com/wp-content/uploads/2023/05/Untitled-340-×-156-px.png Julixa Newman2021-06-21 16:38:352021-06-21 16:38:35Naval Medical Research Center (NMRC) Wound Infections Department Success Stories
The team at NMRC (Naval Medical Research Center) has worked on creating a series of experiments, both in vitro and in vivo, that can be used to test new products from collaborators.